These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3315791)

  • 1. Stable insulin preparation for implanted insulin pumps. Laboratory and animal trials.
    Grau U; Saudek CD
    Diabetes; 1987 Dec; 36(12):1453-9. PubMed ID: 3315791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The programmable implantable medication system (PIMS): design features and pre-clinical trials.
    Saudek CD; Fischell RE; Swindle MM
    Horm Metab Res; 1990 Apr; 22(4):201-6. PubMed ID: 2190901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
    Scavini M; Day PW; Eaton RP
    Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device.
    Blackshear PJ; Rohde TD; Grotting JC; Dorman FD; Perkins PR; Varco RL; Buchwald H
    Diabetes; 1979 Jul; 28(7):634-9. PubMed ID: 446920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin delivery by implanted pumps: one-year trial with programmable infusion systems (the Point Study).
    Walter H
    Int J Artif Organs; 1989 Dec; 12(12):793-8. PubMed ID: 2693370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of polyethylene-lined silicone rubber cannulae in long-term insulin infusion in the dog.
    Wigness BD; Rohde TD; Dorman FD; Buchwald H
    ASAIO Trans; 1986; 32(1):363-6. PubMed ID: 3778735
    [No Abstract]   [Full Text] [Related]  

  • 8. A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules.
    Iacovacci V; Tamadon I; Kauffmann EF; Pane S; Simoni V; Marziale L; Aragona M; Cobuccio L; Chiarugi M; Dario P; Del Prato S; Ricotti L; Vistoli F; Menciassi A
    Sci Robot; 2021 Aug; 6(57):. PubMed ID: 34408097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable insulin pumps: a major piece of computerized diabetes therapy.
    Selam JL
    Horm Metab Res Suppl; 1990; 24():144-54. PubMed ID: 2272620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary trial of the programmable implantable medication system for insulin delivery.
    Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA
    N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of insulin lispro in insulin infusion systems.
    Lougheed WD; Zinman B; Strack TR; Janis LJ; Weymouth AB; Bernstein EA; Korbas AM; Frank BH
    Diabetes Care; 1997 Jul; 20(7):1061-5. PubMed ID: 9203437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable insulin infusion pumps: a case presentation.
    Saudek CD
    Diabetes Educ; 1989; 15(1):44-9. PubMed ID: 2910688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable insulin for implantable delivery systems: in vitro studies with different containers and solvents.
    Selam JL; Zirinis P; Mellet M; Mirouze J
    Diabetes Care; 1987; 10(3):343-7. PubMed ID: 3297579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps.
    Senstius J; Poulsen C; Hvass A
    Diabetes Technol Ther; 2007 Dec; 9(6):517-21. PubMed ID: 18034606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved glycerol/insulin formulation for use in implantable pumps.
    Rohde TD; Kernstine KH; Wigness BD; Kryjeski SR; Dorman FD; Goldenberg FJ; Buchwald H
    ASAIO Trans; 1987; 33(3):316-8. PubMed ID: 3314924
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure to find amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable pump.
    Mauer SM; Buchwald H; Groppoli TJ; Rohde TD; Wigness BD; Rupp WM; Steffes MW
    Diabetologia; 1983 Nov; 25(5):448-50. PubMed ID: 6653944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin delivery.
    Chu MK; Gordijo CR; Li J; Abbasi AZ; Giacca A; Plettenburg O; Wu XY
    Diabetes Technol Ther; 2015 Apr; 17(4):255-67. PubMed ID: 25671341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.